Top 20 of Alzheimer Disease

Article title # Publications/# Citations

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

1984: DDrachman; MFolstein; RKatzman; GMcKhann; DPrice; EMStadlan;

2768

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

2002: JHardy; DJSelkoe;

1558

Neuropathological stageing of Alzheimer-related changes.

1991: EBraak; HBraak;

1463

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

1993: EHCorder; PCGaskell; JLHaines; MAPericak-Vance; ADRoses; AMSaunders; DESchmechel; GWSmall; WJStrittmatter;

1001

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

2002: MAlbert; EBusa; AMDale; MDieterich; BFischl; CHaselgrove; DKennedy; RKilliany; ... SKlaveness; NMakris; AMontillo; BRosen; DHSalat; Avan der Kouwe;

842

Mild cognitive impairment: clinical characterization and outcome.

1999: RJIvnik; EKokmen; RCPetersen; GESmith; EGTangalos; SCWaring;

814

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

2002: RAnwyl; WKCullen; JVFadeeva; IKlyubin; MJRowan; DJSelkoe; DMWalsh; MSWolfe;

746

Alzheimer's disease: genes, proteins, and therapy.

2001: DJSelkoe;

716

Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

1996: PChapman; GCole; CEckman; YHarigaya; KHsiao; SNilsen; FYang; SYounkin;

705

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

2003: CWCotman; CGGlabe; EHead; RKayed; TMMcIntire; SCMilton; JLThompson;

695

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

1991: LBerg; LMBrownlee; BJCrain; AHeyman; JPHughes; DMcKeel; SSMirra; SMSumi; Gvan Belle; FSVogel;

686

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.

2007: CHaass; DJSelkoe;

676

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.

2008: FMBrett; MAFarrell; AGarcía-Muñoz; CALemere; SLi; THMehta; CMRegan; MJRowan; ... BLSabatini; DJSelkoe; GMShankar; NEShepardson; ISmith; DMWalsh;

658

Mild cognitive impairment as a diagnostic entity.

2004: RCPetersen;

639

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.

2006: MSAlbert; DBlacker; RLBuckner; AMDale; RSDesikan; BCDickerson; BFischl; BTHyman; ... RJKilliany; RPMaguire; BTQuinn; FSégonne;

633

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

2003: YAkbari; ACaccamo; TEGolde; RKayed; FMLaFerla; MPMattson; RMetherate; MPMurphy; SOddo; JDShepherd;

586

A specific amyloid-beta protein assembly in the brain impairs memory.

2006: KHAshe; MGallagher; CGGlabe; RKayed; MTKoh; LKotilinek; SLesné; AYang;

583

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

2004: GAntoni; BAusén; JBarletta; MBergström; GBlomqvist; MLDebnath; HEngler; SEstrada; ... DPHolt; GFHuang; WEKlunk; PKoivisto; BLångström; BJLopresti; CAMathis; ANordberg; JCPrice; JSandell; ISavitcheva; AWall; YWang;

575

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

1998: AKBarlow; BAChromy; CEdwards; CEFinch; RFreed; WLKlein; GAKrafft; MPLambert; ... MLiosatos; TEMorgan; IRozovsky; BTrommer; KLViola; PWals; CZhang;

574

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.

2006: SAArmstrong; ICBlat; JPBrunet; SACarr; PAClemons; EDCrawford; TRGolub; SJHaggarty; ... HHieronymus; JLamb; ESLander; JLerner; JWModell; DPeck; MReich; KNRoss; ASubramanian; GWei; RWei; MJWrobel;

565